Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas

NCT01880749 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT01880749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01880749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas
Lead sponsor
NYU Langone Health
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2013
Completion date
December 31, 2019
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

meningiomas, neurofibromatosis type 2, vestibular schwannomas